Australia

Archer Materials completes first phase of graphene-based biosensor prototyping

  • Archer Exploration is now Archer Materials
  • The rename reflects its focus as a materials technology company
  • Archer is progressing its lead assets as it moves to commercialising its technology

We have reached a key development milestone to commercially exploit the IP underpinning the graphene-based biosensor technology.

Archer Materials chief executive officer Dr Mohammad Choucair

What does Archer Materials do?

Archer Materials Ltd (ASX:AXE) is a materials technology company with operations in Sydney and Adelaide, Australia.

The ASX-listed company, previously known as Archer Exploration Limited, recently completed a rename as a materials technology company after making a number of steps towards commercialising its lead assets.

Among these steps is progress in developing its graphene-based biosensor technology along with advancing qubit and biosensor technologies.

The Sydney-headquartered advanced materials business of the company has built a first-phase prototype device (prototype) to test the patterning, printing and performance of graphene inks.

These inks have been produced from an inventory controlled by Archers wholly-owned subsidiary Carbon Allotropes and act as biosensor components.

Archer recently reported that the inks were successfully printed and tested in a biosensing prototype device.

The collaborative company believes its printing process could be duplicated and automated, to facilitate “market-competitive” low-cost prototype production.

Intellectual property ownership for the inks and prototype technologies remain with Archer group which holds a provisional patent for the assets.

The company plans to continue commercialising its biosensor technologies and take its prototypes from proof of concept to patent application stage.

Archer chief executive officer Dr Mohammad Choucair reported this morning: “We have reached a key development milestone to commercially exploit the IP underpinning the graphene-based biosensor technology.

“This achievement provides support for a full patent application that would give Archer exclusive rights to commercially benefit from the IP.

“The materials and processes used to build the prototypes are not prohibitively expensive, which is an advantage in the printable biosensor market.”

Who leads Archer Materials?

Dr Choucair leads Archer with executive chairman Greg English.

Choucair is a Nanotechnology specialist and executive who has more than 12 years experience in commercialisation and deep tech development and has served on the World Economic Forums Global Council for Advanced Materials.

His achievements include inventing the first method known to chemically produce graphene in bulk quantities, to overcome a production limitation by allowing non-graphitic carbon feedstocks to be used in the preparation of graphene, effectively making the material globally accessible.

Lawyer, engineer and chairman English is a partner at Piper Alderman. The experienced director also co-founded Archer and has overseen the companys transition from a South Australian focused minerals exploration company to a diverse materials technology company.

What are Archer Materials next stepsRead More – Source

Related Articles

Back to top button